Accelerating PROTAC Development: A Direct-to-Biology Approach for Rapid Synthesis and Profiling of PROTACS

Advancing Drug Discovery with 3D Spheroid Cancer Models

Assessing the effect of candidate drugs on the phagocytic activity of human iPSC-derived Microglia

BioMarkers Brochure

Biophysical Characterisation of Therapeutic Monoclonal Antibodies – Stability and Forced Degradation Studies

Biophysics Flyer

Computational Drug Target Prioritization for Reversing the Pro-inflammatory Phenotype in Human iPSC-derived Reactive Astrocytes

Development of a Drug Screening Cascade to Identify Novel Potent and Selective NLRP3 Inflammasome Inhibitors

Development of a selective WEE1 inhibitor

Applying understanding of protein structure to support drug discovery progress for Apini Therapeutics

Peptide Immunotherapy Expertise